EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CDK4/6 inhibition reprograms the breast cancer immunopeptidome via Rb-dependent chromatin and transcriptomic remodeling

Robin Minati, Maxime Cahuzac, Julie Perrault, Véronique Lullier, Anca Apavaloaei, Eric Bonneil, Mathieu Courcelles, Joel Lanoix, Eralda Kina, Claude Perreault, Pierre Thibault

Cell Reports · 2025-12 · 44 (12) · 116676

DOI: 10.1016/j.celrep.2025.116676 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2025-12. Verfasst von Robin Minati und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada; Molecular Biology Program, Université de Montré…. Hauptthemen laut MEDLINE: Cyclin-Dependent Kinase 6, Cyclin-Dependent Kinase 4, Retinoblastoma Protein, Breast Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fonds de recherche du Québec, Canadian Breast Cancer Foundation, Quebec Health Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cyclin-Dependent Kinase 6Cyclin-Dependent Kinase 4Retinoblastoma ProteinBreast NeoplasmsChromatinChromatin Assembly and DisassemblyTranscriptomeHumansFemaleBenzimidazolesCell Line, TumorAminopyridinesProtein Kinase InhibitorsAnimalsMice

Stichwörter der Autor:innen

CDK4/6 inhibitorsCP: cancerCP: immunologyabemaciclibbreast cancercancer immunotherapychromatin remodelingimmunopeptidomicsmass spectrometryretinoblastoma proteintumor antigens

Substanzen

Cyclin-Dependent Kinase 6Cyclin-Dependent Kinase 4Retinoblastoma ProteinabemaciclibBenzimidazolesChromatinAminopyridinesCDK6 protein, humanCDK4 protein, humanProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Institute of Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada; Molecular Biology Program, Université de Montréal, Montréal, QC H3T 1J4, Canada.
  • Institute of Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada.
  • Institute of Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada; Department of Medicine, Université de Montréal, Montréal, QC H3T 1J4, Canada. Electronic address: claude.perreault@um…
  • Institute of Research in Immunology and Cancer, Université de Montréal, Montréal, QC H3T 1J4, Canada; Department of Chemistry, Université de Montréal, Montréal, QC H3T 1J4, Canada. Electronic address: pierre.thibault@um…

Förderung

  • Fonds de recherche du Québec
  • Canadian Breast Cancer Foundation
  • Quebec Health Research Fund
  • Canada Foundation for Innovation

Zitieren

APA

Minati, R., Cahuzac, M., Perrault, J., Lullier, V., Apavaloaei, A., Bonneil, E., Courcelles, M., Lanoix, J., Kina, E., Perreault, C., & Thibault, P. (2025). CDK4/6 inhibition reprograms the breast cancer immunopeptidome via Rb-dependent chromatin and transcriptomic remodeling. Cell Reports, 44(12), 116676. https://doi.org/10.1016/j.celrep.2025.116676

Vancouver

Minati R, Cahuzac M, Perrault J, Lullier V, Apavaloaei A, Bonneil E, et al. CDK4/6 inhibition reprograms the breast cancer immunopeptidome via Rb-dependent chromatin and transcriptomic remodeling. Cell Reports. 2025;44(12):116676. doi:10.1016/j.celrep.2025.116676

BibTeX
@article{Minati2025,
  author = {Minati, Robin and Cahuzac, Maxime and Perrault, Julie and Lullier, Véronique and Apavaloaei, Anca and Bonneil, Eric and Courcelles, Mathieu and Lanoix, Joel and Kina, Eralda and Perreault, Claude and Thibault, Pierre},
  title = {CDK4/6 inhibition reprograms the breast cancer immunopeptidome via Rb-dependent chromatin and transcriptomic remodeling},
  journal = {Cell Reports},
  year = {2025},
  volume = {44},
  number = {12},
  pages = {116676},
  doi = {10.1016/j.celrep.2025.116676}
}
Kostenlos starten →